Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
July-2014 Volume 34 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2014 Volume 34 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Chrysanthemum zawadskii extract induces hair growth by stimulating the proliferation and differentiation of hair matrix

  • Authors:
    • Zheng Li
    • Jingjie Li
    • Lijuan Gu
    • Shahnaz Begum
    • Yunbo Wang
    • Baishen Sun
    • Mira Lee
    • Changkeun Sung
  • View Affiliations / Copyright

    Affiliations: Department of Food Science and Technology, College of Agriculture and Biotechnology, Chungnam National University, Daejeon, Chungnam 305-764, Republic of Korea, College of Chemistry, Taizhou University, Linhai, Zhejiang 317000, P.R. China
  • Pages: 130-136
    |
    Published online on: May 2, 2014
       https://doi.org/10.3892/ijmm.2014.1768
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Chrysanthemum zawadskii has been proven to possess hair growth activity and has been used as treatment for hair loss. The aim of this study was to provide a novel explanation of the mechanism by which Chrysanthemum zawadskii extracts (CZe) promote hair growth and to characterize the affected hair follicle (HF) regions and the progression of growth. The n-butanol and water fractions of CZe were used for hair growth induction by topical application to the backs of C57BL/6 mice for up to 30 days. To investigate cell development during HF morphogenesis, bromodeoxyuridine-labeled skin sections were detected using immunohistochemistry. The results showed that the water fraction of CZe promoted hair shaft production and induced premature entry of telogen HFs into the anagen. Subsequently, immunohistochemical studies indicated that the water fraction of CZe stimulated the differentiation and proliferation of pluripotent epidermal matrix cells in the matrix region and epithelial stem cells in the basal layer of the epidermis. Additionally, flavonoids were identified as effective constituents. Therefore, the findings of this study suggested that the water fraction of CZe may be developed as a therapeutic agent for the prevention of hair loss.

Introduction

Chrysanthemum zawadskii var. latilobum (CZ), is an annual and perennial herb with noteworthy flowers, which has been used in traditional medicine for the treatment of inflammatory diseases, gastroenteric disorders, bladder-related disorders and hypertension (1). The effective constituents comprised terpenoids and essential oils, as well as flavonoids and polysaccharides. Terpenoids and flavonoids are considered the active pharmaceutical ingredients (2), and flower extracts have been shown to have numerous pharmacological properties, including anti-allergic, anti-inflammatory and anticancer activities (3–5).

The hair follicle (HF) is a mammalian skin organ that produces hair that follows a specific growth cycle with three distinct and concurrent phases: anagen, catagen and telogen (6). Findings of previous studies on HF morphogenesis demonstrated that bulge (a niche for adult stem cells) stem cells migrate downwards and enter the matrix where they rapidly proliferate and differentiate to form HFs (7–10). During anagen, follicles are long and straight, and the proliferating matrix cells have a cycle length of ~18 h. Dead cells degenerate as they reach the upper follicle, releasing the hair shaft which then continues through the skin surface. The duration of anagen determines the hair shaft length and is dependent on the continued proliferation and differentiation of matrix cells in the matrix region of the HF (11).

Animal models comprising a variety of species, including mice, rats, sheep, rabbits and monkeys, are an important tool in the study of hair growth. However, murine models are widely used for hair growth studies due to the availability of large databases and specific mutants such as nude, hairless, rhino, and severe combined immunodeficient mice (12,13). To achieve perfectly synchronized anagen induction, black pigmentation of C57BL/6 or C3H mice in dorsal skin is employed. This is the most commonly used site for the observation of anagen initiation as the truncal epidermis in this species lacks melanin-producing melanocytes and melanin production is strictly connected with the anagen phase of hair growth (14,15).

In recent years, traditional herb medicines, such as eclipta alba, asiasari radix, panax ginseng and schisandra nigra, have been widely used for hair growth studies. Eclipta alba induced telogen to anagen transition and was positive for FGF-7 and Shh and negative for BMP4 (12,16). Asiasari radix was demonstrated to stimulate hair growth in C57BL/6 and C3H mice by increasing the proliferation of HaCaT and human dermal papilla cells (DPCs) and inducing the expression of VEGF in human DPCs (17). The topical application of the schisandra nigra extract enhanced hair growth by increasing the expression of proliferating cell nuclear antigen (PCNA), proliferation of immortalized vibrissa dermal papilla cells, and downregulation of transforming growth factor-β2 (TGF-β2) in the bulb matrix region (18). The main molecular components in panax ginseng are ginsenosides which are known to improve cell proliferation of human DPCs through anti-apoptotic activation (19). In the present study, four fractions of CZes were used for the induction of hair growth in order to examine the mechanism of hair growth using immunohistochemistry.

Materials and methods

Extract preparation

Dried whole plants of CZ were purchased from Jecheon Medicinal Herb, Inc. (Jecheon, Korea). The dried plant of CZ was crushed and extracted using 70% ethanol by ultrasonic extraction for 2 h. The filtered liquid from the extraction was concentrated in a rotary vacuum evaporator (Eyela N-N, Tokyo, Japan). The residues were then diluted with deionized water. The extracted sample was layered step by step using the dissolvents: petroleum ether, diethyl ether, and n-butanol. Following collection, concentration and quantification, petroleum ether, diethyl ether, n-butanol and water fractions were dissolved in 70% ethanol with a final concentration of 5%. A systematic investigation of cell development on hair regeneration using water fraction was then conducted.

Experimental procedures

Eight-week-old, female C57BL/6 mice were used for all the experimental procedures. The animals were purchased from Danhan Biolink, Inc. (Eumseong, Korea). Animal experiments were conducted in accordance with the NIH guide for the care and use of laboratory animals. The animals were housed under conventional conditions with food/water available ad libitum and 12-h light cycle. Mice were divided into five groups (n=7 per group). All the mice were depilated topically with depilatory cream on dorsal skin. Each mouse was administered a variety of CZe at a dose of 1,600 mg/kg body weight by daily topical application for 30 days. The conversion of each phase was recorded on a daily basis.

Bromodeoxyuridine (BrdU) labeling

BrdU is an analogue of thymidine, which is incorporated into newly synthesized DNA of replicating cells (S-phase of the cell cycle), substituting for thymidine during DNA replication. It is commonly used in the detection of proliferating and surviving cells in living tissues (20,21). As a proliferative marker of adult epithelium, the timing of BrdU injection is a critical factor in differentiating newly proliferated cells from epidermal label-retaining cells (22). In order to investigate cell development in different hair growth stages and to ensure that the results reflected the true level of cell proliferation and survival stimulated by CZes, a single and a timed injection of BrdU were used for measuring cell proliferation and survival independently in different time periods (Fig. 1). To detect cell proliferation, BrdU was administered by intraperitoneal injection (160 μg/g of body weight; Sigma, St. Louis, MO, USA) 24 h prior to mice being sacrificed at day 8, 16 and 21. To detect cell survival, the mice were injected with BrdU (160 μg/g of body weight) every 12 h for a total of six injections prior to the 3 days of depilation, followed by a chase of 19 days. At day 22, mice were then sacrificed and the surviving BrdU-positive cells were detected as described in subsequent sections.

Figure 1

Experimental design for labeling of cell proliferation and survival during different phases of hair growth.

Quantification of BrdU-positive cells

The quantification and analysis of BrdU-positive cells was performed as previously described with some modifications (23,24). Briefly, a random selection of seven complete HFs and equal length of epidermis tissues in each skin section was counted. The BrdU-labeled cells in the different parts of the HF were counted in each follicular section by an observer who was blinded to the study. All counts were performed at a magnification of ×400 and ×1,000 under a light microscope (Olympus BX41; Olympus, Tokyo, Japan). A cell was counted as being in the matrix region of the HF if it was in contact with or in the matrix region. The mean number of labeled cells in each part of the HF and epidermis were used for comparison.

Histology and immunohistochemistry

Paraffin-embedded skin tissues were sectioned and attached to positively charged slides. Histology was carried out using H&E (Mayer hematoxylin and eosin; Sigma) staining. Immunohistochemical analysis of skin sections was performed as previously described (25). Briefly, the sections were deparaffinized and rehydrated in graded ethanol and placed in 100 mM phosphate-buffered saline (PBS) for 10 min prior to initiating the staining procedure. The sections were then sequentially incubated with peroxidase quenching solution (28% H2O2: absolute pure methanol, 1:9, v:v) to eliminate the endogenous peroxidase activity for 10 min. After incubation with the blocking solution (Life Technologies, Carlsbad, CA, USA) for 15 min, the blotted slides (without washing) were incubated with anti-BrdU primary antibody (1:200; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), in a moist chamber, at room temperature (RT) for 3 h. Subsequently, the sections were incubated with a biotinylated secondary antibody (Life Technologies) for 20 min at RT. After staining in 3,3′-diaminobenzidine (DAB), slides were dehydrated in a grade series of alcohol and xylene. The sections were then mounted with Histomount (Life Technologies).

Statistical analysis

Data were evaluated statistically using one-way analysis of variance or the Student’s t-test. Data were expressed as the mean number of proliferating and surviving cells ± the standard deviation. The significant difference between the values for the various experimental and control groups was set at P<0.05.

Results

Water and n-butanol fractions of the CZe induce early onset anagen transition from telogen

Hair growth initiation time was significantly reduced following treatment with the water fraction of CZe. C57BL/6 murine dorsal hair is known to have a time-synchronized hair growth cycle and the dorsal skin pigmentation was considered as evidence for the transition of hair growth stages. Following topical application onto the backs of mice for up to 7 days, the water fraction of the CZe induced premature entry of telogen HFs into anagen whereas the vehicle (70% ethanol, control) showed no anagen induction until day 9 (Fig. 2A). The percentage of black pigmentation was observed during anagen-telogen development in the mice treated with CZes. These results suggested that CZes, including the n-butanol and water fractions, significantly induce anagen elongation (Fig. 2B). At day 22, the mean hair shaft length was observed in the telogen stage (Table I), which showed that the water fraction of the CZe stimulated hair fiber production. Statistical analysis demonstrated that the water fraction of the CZe markedly increased the HF size, and an increase was observed in the diameter of the matrix region (P=0.053) and the HF length (Table I). In addition, no inflammation, scaling or drying of skin was observed at the site of application in any of the animals during the experimental procedure. The petroleum ether and diethyl ether fractions did not show anagen induction and hair shaft elongation (data not shown).

Figure 2

N-butanol and water fractions of Chrysanthemum zawadskii extracts (CZe) induced premature anagen transition. (A) Daily topical application for 7 and 9 days after depilation. Note the daily hair growth observed in the CZe-treated group. (B) The ratio of the anagen phase on dorsal skin at days 8–12. *P<0.05, **P<0.01 vs. the control.

Table I

In vivo effect of Chrysanthemum zawadskii extracts on hair growth.

Table I

In vivo effect of Chrysanthemum zawadskii extracts on hair growth.

Anagen (Day 9)Telogen (Day 22)


MeasurementsN-butanol fractionWater fractionControlN-butanol fractionWater fractionControl
Hair shaft length (mm)---10.57±0.5011.37±0.55a10.40±0.76
Hair follicle counts (2.2 mm longitudinal section)17.00±3.5815.33±2.5817.33±2.2511.37±1.7712.00±1.41b9.75±1.49
Diameter of follicle matrix (μm)83.00±12.9092.50±9.38c81.00±8.8131.55±1.2435.45±4.6631.78±3.7
Hair follicle length (μm)779.00±86.99 909.83±82.64b756.67±98.24234.93±13.21240.13±19.49224.15±9.63
Dermis thickness (μm)505.00±33.65513.00±53.05501.17±26.87241.87±30.31224.65±17.09276.37±14.91

{ label (or @symbol) needed for fn[@id='tfn1-ijmm-34-01-0130'] } Values are the mean ± standard deviation (SD), n=6.

a P<0.01,

b P<0.05 and

c P=0.053, significance vs. control.

The water fraction of the CZe causes hyperproliferation in the basal layer of the epidermis

During anagen initiation, the bulge (niche of multipotent stem cells) stem cells migrate out of the follicle to generate sebaceous glands and epidermis (9,26,27). In this study, the water fraction of CZe induced a 2-fold increase in the growth of the epidermis compared to the control and n-butanol fraction groups (Fig. 3A–D). To understand whether the thickening of the epidermis was due to increased proliferation in the basal layer of the epidermis, the proliferation index of BrdU incorporated by using immunohistochemistry at day 9 was measured. The results indicated that the water fraction of the CZe increased proliferation in the basal layer of the epidermis (Fig. 3E–H).

Figure 3

Histological analysis and quantification of proliferating bromodeoxyuridine (BrdU+) cells in the basal layer of the epidermis. (A–C) Hematoxylin and eosin (H&E) staining of the epidermis. (A) Control, (B) n-butanol fraction and (C) water fraction. (D) Induction of epidermal thickness following exposure to the water fraction of CZ. The thickness of the epidermis in mice exposed to the water fraction of CZ is 2-fold greater than that observed in the control and the n-butanol fraction. An example, at day 9, is the labeled retaining cells in the basal layer of the epidermis. (E) Control, (F) n-butanol fraction, (G) water fraction. (H) Quantification of proliferating cells after 24 h. Scale bar, 50 μm. Black arrows indicate (A–C) the change of the epidermis, and (E–G) the labeling of proliferated cells in the basal layer of the epidermis. **P<0.01, ***P<0.001 vs. control.

The water fraction of the CZe increases cell proliferation in anagen and telogen of matrix HFs

Cell proliferation and differentiation in the matrix is required for HF formation. Pluripotent epidermal matrix cells, which have dermal papilla at their base, in the hair bulb move upward while cells at the center of the follicle become the medulla of the hair shaft (26,28). To investigate whether the increase of the hair shaft occurred to hyperproliferation in the matrix region, we traced the cell development of hair matrix during the anagen to telogen transition. The results suggested that the water fraction of the CZe markedly increased cell proliferation during the anagen phase of hair matrix (Fig. 4E–H). Additionally, the quantity of proliferating BrdU+ cells in telogen demonstrated that the activation of hyperproliferation in the matrix was maintained in the telogen stage (Fig. 5I–L). Moreover, when the quantification of cell proliferation and survival in the epidermis was performed at day 22, the statistical index showed that the water fraction of CZe stimulated proliferation in the basal layer of the epidermis and not only in anagen (Fig. 5A–D), increasing the number of surviving cells (Fig. 5E–H). In addition, the n-butanol and water fractions of the CZe had no effect on proliferation in the mid-section of the HFs (Fig. 4A–D) and no effect on cell survival in the telogen stage of HF (data not shown).

Figure 4

Immunohistochemical analysis of bromodeoxyuridine (BrdU+) retention in anagen of hair follicles. (A–C) Location of proliferating cells in the mid-sections of the hair follicles. (A) Control, (B) n-butanol fraction and (C) water fraction. (D) Quantification of proliferated cells after 24 h. (E–F) Location of proliferated cells in hair matrix. (E) Control, (F) n-butanol fraction and (G) water fraction. (H) The water fraction induced hyperproliferation in the hair matrix. Scale bar, 25 μm. **P<0.01 vs. control.

Figure 5

Immunohistochemical analysis of bromodeoxyuridine (BrdU+) cells retained in telogen at day 22. (A–C) Proliferating BrdU+ cells in the basal layer of the epidermis. (A) Control; (B) n-butanol fraction; and (C) water fraction. (D) The water fraction of Chrysanthemum zawadskii extracts (CZe) stimulates cell proliferation in telogen epidermis within 24 h as shown by the quantification of surviving cells in the epidermis. (E) Control; (F) n-butanol fraction; and (g) water fraction. (H) The water fraction of CZe increases the number of surviving cells, and elongate the cell life-span. (J–K) Location of proliferating BrdU+ cells in telogen hair follicles. (I) Control, (J) n-butanol fraction, and (K) water fraction. UF, upper follicle; SG, sebaceous gland; M, matrix; SHG, secondary hair germ. Red arrows show the cell proliferation in SG. Black arrows indicate the labeling of proliferated and survived cells in the epidermis and hair follicles. (L) Quantity of proliferating BrdU+ cells in the telogen of hair follicles. Scale bar, 25 μm. *P<0.05; **P<0.01 vs. control.

Discussion

In the present study, we have shown that when the shaved skin of C57BL/6 mice is treated with topical application of water and n-butanol fractions of CZe for 25 days, new hair morphogenesis is initiated in the shaved area, with the initiation time for this process to occur also being significantly reduced when compared to vehicle-treated mice. In order to elucidate the biological mechanism by which CZes induce early onset anagen transition; we investigated cell development in full-thickness skin by using BrdU incorporation. The results indicate that the water fraction of the CZe promoted cell proliferation in the basal layer of the epidermis and induced the proliferation and differentiation of epidermal matrix cells in anagen and telogen of HFs. During anagen, the new HF morphogenesis was initiated by a number of pluripotent stem cells that are normally present in the bulge region, including epithelial stem cells. These stem cells migrate downwards into the regenerating epithelium where they can differentiate into at least eight different cell lines, forming the ORS, companion layer, Henle’s layer, Huxley’s layer, cuticle of the IRS, cuticle of the hair shaft, shaft cortex and shaft medulla (29,30). It is also known that the lower region of the whisker follicle contains cells that respond to skin morphogenetic signals by upward and downward migration and form epidermis, HFs and sebaceous glands (9,31). Thus, we hypothesized that the hyperproliferation in the basal layer of the epidermis may occur via stimulation of the migration and differentiation of epithelial stem cells during anagen initiation, and that the premature entry of telogen HFs into anagen may occur through the induction of epithelial stem cell downward migration and differentiation to form the new dermal papilla and hair germ. In addition, stimulation of differentiation and proliferation of pluripotent epidermal matrix cells in the matrix region may be one of the mechanisms by which the water fraction of CZes increase the hair shaft length and the HF size.

Previously, we had performed the screening test by using crude extracts of herb medicines (17,18). The results indicated that ZC crude extract showed a marked induction on anagen initiation. To investigate the effective constituent on hair growth in CZ crude extract, the petroleum ether, diethyl ether, n-butanol and water fractions of CZe, were used in the present study. Petroleum ether and diethyl ether fractions did not show induction on anagen initiation and hair shaft production. Thus, liposoluble terpenoids, sterols and essential oils, as the main components, did not stimulate hair growth. By contrast, flavonoids, the main bioactive constituents in n-butanol and water fractions, were considered as effective constituents. Notably, quercetin, luteolin and linarin, the main flavonoids in CZe, should be studied in future studies to determine whether they serve as potential effective compounds.

HF is a mammalian skin organ that produces hair in a process that occurs in phases, including the growth, regression and resting phases. The migration and differentiation of epithelial stem cells is principally responsible for hair production (27,32). Anagen is the active growth phase responsible for forming the HF and hair fiber. During this phase the roots of the hair divide rapidly and add to the hair shaft (32). To understand the mechanism of CZe stimulation of hair shaft production, we labeled the cell proliferation in the different time-points and noted the residence time of anagen. The results demonstrate that stimulation of differentiation in hair matrix is probably initiated by the water fraction of the CZe. The appearance of black pigmentation was taken as the anagen initiation (33). Thus, the premature entry into anagen was considered as an important symbol of migration and differentiation of epithelial stem cells. Following treatment with the water fraction of the CZe, the epithelial stem cells were activated and migrated upward and downward, subsequently differentiating rapidly to form the interfollicular epidermis and new HF during anagen phase. In consideration of these findings, we suggest the hypothetical model shown in Fig. 6 (red arrows show the potential pathway).

Figure 6

The proposed mechanism for Chrysanthemum zawadskii regulation of anagen initiation and hair shaft production. i) Anagen initiation leads to the induction of bulge stem cell migration up- and downward, with stem cells differentiating to form the epidermis and new hair germ. ii) Stimulation of epidermal matrix cell proliferation and differentiation. iii) Promotion of the differentiation of adult progenitor and precursor cells to form the hair shaft. Red arrows indicate the potential pathway; black arrows indicate the hypothetical pathway.

Hair cycle is regulated by the interplay of stimulatory and inhibitory growth factors in mice and humans (6). Previous studies on the induction of hair growth as a result of CZ application, reported that CZes promote proliferation of a human keratinocyte cell line and human dermal papilla cells in vitro, and subsequently, suggested that jaceosidin and eupatilin, which are both derived from CZ, had the potential to promote hair growth through the downregulation of TGF-β by the jaceosidin-dependent upregulation of VEGF and Bcl-2 upregulation by eupatilin (34). In the present study, we did not investigate the signaling pathways involved but performed a novel evaluation in order to clarify the mechanism by which CZes promote hair growth using cell labeling and tracing. It provided a more precise measure of which fraction in CZes is responsible for hair growth and may therefore provide a more reliable molecular basis for potential clinical application.

In conclusion, as a traditional herb used as medicine, Chrysanthemum zawadskii may have wide potential in clinical application. It has few side effects; no local inflammation, pruritus, edema, or scaling of skin were observed during the application procedure. The present study has located the effective region of hair growth, identified a more accurate timeline by which growth occurs and provided a novel explanation of the mechanism by which CZes promote hair growth through the regulation of cell development at different time periods. Further analysis of these results as well as a more detailed evaluation of the molecular mechanism by which CZes induce proliferation of hair growth are required before its potential can be completely realized in the clinic.

Acknowledgements

The authors would like to thank Dr Kang-Ju Choi for guidance in the process of herb extract and isolation. This study was supported by the DBIO Science Food and Technology Corporation.

References

1 

Han S, Sung KH, Yim D, et al: The effect of linarin on LPS-induced cytokine production and nitric oxide inhibition in murine macrophages cell line RAW264.7. Arch Pharm Res. 25:170–177. 2002. View Article : Google Scholar : PubMed/NCBI

2 

Shim SY, Kang HS, Sun HJ, et al: Isolation and identification of flavonoids from Gujeolcho (Chrysanthemum zawadskii var. latilobum) as inhibitor of histamine release. Food Sci Biotechnol. 21:613–617. 2012. View Article : Google Scholar

3 

Seo JY, Lim SS, Park J, et al: Protection by Chrysanthemum zawadskii extract from liver damage of mice caused by carbon tetrachloride is maybe mediated by modulation of QR activity. Nutr Res Pract. 4:93–98. 2010.

4 

Singh RP, Agrawal P, Yim D, Agarwal C and Agarwal R: Acacetin inhibits cell growth and cell cycle progression, and induces apoptosis in human prostate cancer cells: structure-activity relationship with linarin and linarin acetate. Carcinogenesis. 26:845–854. 2005. View Article : Google Scholar

5 

Hsu YL, Kuo PL and Lin CC: Acacetin inhibits the proliferation of Hep G2 by blocking cell cycle progression and inducing apoptosis. Biochem Pharmacol. 67:823–829. 2004. View Article : Google Scholar : PubMed/NCBI

6 

Stenn KS and Paus R: Controls of hair follicle cycling. Physiol Rev. 81:449–494. 2001.PubMed/NCBI

7 

Li LH and Xie T: Stem cell niche: Structure and function. Annu Rev Cell Dev Biol. 21:605–631. 2005. View Article : Google Scholar

8 

Blanpain C and Fuchs E: Epidermal stem cells of the skin. Annu Rev Cell Dev Biol. 22:339–373. 2006. View Article : Google Scholar : PubMed/NCBI

9 

Gambardella L and Barrandon Y: The multifaceted adult epidermal stem cell. Curr Opin Cell Biol. 15:771–777. 2003. View Article : Google Scholar : PubMed/NCBI

10 

Reya T and Clevers H: Wnt signalling in stem cells and cancer. Nature. 434:843–850. 2005. View Article : Google Scholar : PubMed/NCBI

11 

Alonso L and Fuchs E: The hair cycle. J Cell Sci. 119:391–393. 2006. View Article : Google Scholar : PubMed/NCBI

12 

Datta K, Singh AT, Mukherjee A, Bhat B, Ramesh B and Burman AC: Eclipta alba extract with potential for hair growth promoting activity. J Ethnopharmacol. 124:450–456. 2009. View Article : Google Scholar

13 

Sundberg JP and King LE Jr: Mouse models for the study of human hair loss. Dermatol Clin. 14:619–632. 1996. View Article : Google Scholar : PubMed/NCBI

14 

Slominski A, Paus R and Costantino R: Differential expression and activity of melanogenesis-related proteins during induced hair growth in mice. J Invest Dermatol. 96:172–179. 1991. View Article : Google Scholar : PubMed/NCBI

15 

Slominski A, Paus R, Plonka P, et al: Melanogenesis during the anagen-catagen-telogen transformation of the murine hair cycle. J Invest Dermatol. 102:862–869. 1994. View Article : Google Scholar : PubMed/NCBI

16 

Roy RK, Thakur M and Dixit VK: Hair growth promoting activity of Eclipta alba in male albino rats. Arch Dermatol Res. 300:357–364. 2008. View Article : Google Scholar : PubMed/NCBI

17 

Rho SS, Park SJ, Hwang SL, et al: The hair growth promoting effect of Asiasari radix extract and its molecular regulation. J Dermatol Sci. 38:89–97. 2005. View Article : Google Scholar : PubMed/NCBI

18 

Kang JI, Kim SC, Hyun JH, et al: Promotion effect of Schisandra nigra on the growth of hair. Eur J Dermatol. 19:119–125. 2009.

19 

Kim JH, Yi SM, Choi JE and Son SW: Study of the efficacy of Korean red ginseng in the treatment of androgenic alopecia. J Ginseng Res. 33:223–228. 2009. View Article : Google Scholar

20 

Konishi T, Takeyasu A, Natsume T, Furusawa Y and Hieda K: Visualization of heavy ion tracks by labeling 3′-OH termini of induced DNA strand breaks. J Radiat Res. 52:433–440. 2011.PubMed/NCBI

21 

Smith PJ, Howes EA and Treherne JE: Cell proliferation in the repairing adult insect central nervous system: incorporation of the thymidine analogue 5-bromo-2-deoxyuridine in vivo. J Cell Sci. 95:599–604. 1990.

22 

Nijhof JG, van Pelt C, Mulder AA, Mitchell DL, Mullenders LH and de Gruijl FR: Epidermal stem and progenitor cells in murine epidermis accumulate UV damage despite NER proficiency. Carcinogenesis. 28:792–800. 2007. View Article : Google Scholar : PubMed/NCBI

23 

Blanpain C, Lowry WE, Geoghegan A, Polak L and Fuchs E: Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche. Cell. 118:635–648. 2004. View Article : Google Scholar : PubMed/NCBI

24 

Sarin KY, Cheung P, Gilison D, et al: Conditional telomerase induction causes proliferation of hair follicle stem cells. Nature. 436:1048–1052. 2005. View Article : Google Scholar : PubMed/NCBI

25 

Liu L, Hoang-Gia T, Wu H, et al: Ginsenoside Rb1 improves spatial learning and memory by regulation of cell genesis in the hippocampal subregions of rats. Brain Res. 1382:147–154. 2011. View Article : Google Scholar : PubMed/NCBI

26 

Alonso L and Fuchs E: Stem cells of the skin epithelium. Proc Natl Acad Sci USA. 100:11830–11835. 2003. View Article : Google Scholar

27 

Cotsarelis G: Epithelial stem cells: a folliculocentric view. J Invest Dermatol. 126:1459–1468. 2006. View Article : Google Scholar : PubMed/NCBI

28 

Spradling A, Drummond-Barbosa D and Kai T: Stem cells find their niche. Nature. 414:98–104. 2001. View Article : Google Scholar : PubMed/NCBI

29 

Krause K and Foitzik K: Biology of the hair follicle: the basics. Semin Cutan Med Surg. 25:2–10. 2006. View Article : Google Scholar : PubMed/NCBI

30 

Reynolds AJ and Jahoda CA: Hair follicle stem cells? A distinct germinative epidermal cell population is activated in vitro by the presence of hair dermal papilla cells. J Cell Sci. 99:373–385. 1991.PubMed/NCBI

31 

Oshima H, Rochat A, Kedzia C, Kobayashi K and Barrandon Y: Morphogenesis and renewal of hair follicles from adult multipotent stem cells. Cell. 104:233–245. 2001. View Article : Google Scholar : PubMed/NCBI

32 

Paus R and Cotsarelis G: The biology of hair follicles. N Engl J Med. 341:491–497. 1999. View Article : Google Scholar

33 

Peters EMJ, Botchkarev VA, Müller-Röver S, Moll I, Rice FL and Paus R: Developmental timing of hair follicle and dorsal skin innervation in mice. J Comp Neurol. 448:28–52. 2002. View Article : Google Scholar : PubMed/NCBI

34 

Pi LQ, Jin XH, Kim K, et al: Effects of Chrysanthemum zawadskii extract on hair growth in vivo and in vitro. Exp Dermatol. 19:5822010.

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Li Z, Li J, Gu L, Begum S, Wang Y, Sun B, Lee M and Sung C: Chrysanthemum zawadskii extract induces hair growth by stimulating the proliferation and differentiation of hair matrix. Int J Mol Med 34: 130-136, 2014.
APA
Li, Z., Li, J., Gu, L., Begum, S., Wang, Y., Sun, B. ... Sung, C. (2014). Chrysanthemum zawadskii extract induces hair growth by stimulating the proliferation and differentiation of hair matrix. International Journal of Molecular Medicine, 34, 130-136. https://doi.org/10.3892/ijmm.2014.1768
MLA
Li, Z., Li, J., Gu, L., Begum, S., Wang, Y., Sun, B., Lee, M., Sung, C."Chrysanthemum zawadskii extract induces hair growth by stimulating the proliferation and differentiation of hair matrix". International Journal of Molecular Medicine 34.1 (2014): 130-136.
Chicago
Li, Z., Li, J., Gu, L., Begum, S., Wang, Y., Sun, B., Lee, M., Sung, C."Chrysanthemum zawadskii extract induces hair growth by stimulating the proliferation and differentiation of hair matrix". International Journal of Molecular Medicine 34, no. 1 (2014): 130-136. https://doi.org/10.3892/ijmm.2014.1768
Copy and paste a formatted citation
x
Spandidos Publications style
Li Z, Li J, Gu L, Begum S, Wang Y, Sun B, Lee M and Sung C: Chrysanthemum zawadskii extract induces hair growth by stimulating the proliferation and differentiation of hair matrix. Int J Mol Med 34: 130-136, 2014.
APA
Li, Z., Li, J., Gu, L., Begum, S., Wang, Y., Sun, B. ... Sung, C. (2014). Chrysanthemum zawadskii extract induces hair growth by stimulating the proliferation and differentiation of hair matrix. International Journal of Molecular Medicine, 34, 130-136. https://doi.org/10.3892/ijmm.2014.1768
MLA
Li, Z., Li, J., Gu, L., Begum, S., Wang, Y., Sun, B., Lee, M., Sung, C."Chrysanthemum zawadskii extract induces hair growth by stimulating the proliferation and differentiation of hair matrix". International Journal of Molecular Medicine 34.1 (2014): 130-136.
Chicago
Li, Z., Li, J., Gu, L., Begum, S., Wang, Y., Sun, B., Lee, M., Sung, C."Chrysanthemum zawadskii extract induces hair growth by stimulating the proliferation and differentiation of hair matrix". International Journal of Molecular Medicine 34, no. 1 (2014): 130-136. https://doi.org/10.3892/ijmm.2014.1768
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team